Patent · US Active

Substituted 8-heteroaryl xanthines

US7732455B2 · kind B2 · utility

6Cited by
13References
102Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 14, 2007
Grant dateJun 8, 2010
Priority date
Expiry dateDec 14, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D473/08
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Selective antagonists of A2B adenosine receptors like those of formula I are provided.These compounds and compositions are useful as pharmaceutical agents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.